The African American Outreach Core (AAOC) supports the aims of the Washington University Knight Alzheimer's Disease Research Center. The AAOC strives to increase the diversity of the Knight ADRC participant pool by recruiting African Americans (AAs), the largest minority group in the metropolitan St. Louis area. The AAOC assists in the recruitment and retention of African American participants to support all Knight ADRC studies and projects, defines and addresses barriers to participation; evaluates and makes recommendations in the home setting to demented patients and their families, and develops and provides minority outreach programs targeted at potential participants, their families, and healthcare providers who serve the AA community. In this renewal, the AAOC will continue to lead recruitment and retention of AA participants in close collaboration with Knight ADRC components, particularly by being fully integrated with the Clinical and Outreach Recruitment and Education (OREC) Cores and the African American Advisory Board. Our goal is to ensure that of the new participants enrolled in the Knight ADRC Clinical Core, at least 20% are AA to maintain the percentage of AA participants in the Knight ADRC Clinical Core at 17% or higher through the next five years. The AAOC will continue to conduct home-based cognitive assessments to provide a dementia diagnosis to AA elderly and to address any barriers to participation in our research studies. In this renewal, we have the additional Aim to screen, address, and modify mobility and/or safety concerns (e.g., transportation and impaired driving, risk for falls, medication compliance) in our home dementia assessment program.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005681-36
Application #
9697257
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
2021-04-30
Budget Start
2019-05-01
Budget End
2020-04-30
Support Year
36
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Cruchaga, Carlos; Del-Aguila, Jorge L; Saef, Benjamin et al. (2018) Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms. Alzheimers Dement 14:205-214
Hanfelt, John J; Peng, Limin; Goldstein, Felicia C et al. (2018) Latent classes of mild cognitive impairment are associated with clinical outcomes and neuropathology: Analysis of data from the National Alzheimer's Coordinating Center. Neurobiol Dis 117:62-71
Peloso, Gina M; van der Lee, Sven J; International Genomics of Alzheimer's Project (IGAP) et al. (2018) Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease. Alzheimers Dement (Amst) 10:595-598
Kinnunen, Kirsi M; Cash, David M; Poole, Teresa et al. (2018) Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study. Alzheimers Dement 14:43-53
Kim, Sungsu; Maynard, Jason C; Strickland, Amy et al. (2018) Schwann cell O-GlcNAcylation promotes peripheral nerve remyelination via attenuation of the AP-1 transcription factor JUN. Proc Natl Acad Sci U S A 115:8019-8024
Sato, Chihiro; Barthélemy, Nicolas R; Mawuenyega, Kwasi G et al. (2018) Tau Kinetics in Neurons and the Human Central Nervous System. Neuron 98:861-864
Schultz, Stephanie A; Gordon, Brian A; Mishra, Shruti et al. (2018) Widespread distribution of tauopathy in preclinical Alzheimer's disease. Neurobiol Aging 72:177-185
Oxtoby, Neil P; Young, Alexandra L; Cash, David M et al. (2018) Data-driven models of dominantly-inherited Alzheimer's disease progression. Brain 141:1529-1544
Hettinger, Jane C; Lee, Hyo; Bu, Guojun et al. (2018) AMPA-ergic regulation of amyloid-? levels in an Alzheimer's disease mouse model. Mol Neurodegener 13:22
Bonham, Luke W; Karch, Celeste M; Fan, Chun C et al. (2018) CXCR4 involvement in neurodegenerative diseases. Transl Psychiatry 8:73

Showing the most recent 10 out of 952 publications